HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
4
Cubic Digital Technology
300344
5
HNAC Technology
300490
US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 4.440
- -0.350-7.31%
Trading Feb 18 14:13 ET
159.17MMarket Cap-2.14P/E (TTM)
4.800High4.440Low132.45KVolume4.800Open4.790Pre Close613.65KTurnover1.26%Turnover RatioLossP/E (Static)35.85MShares26.62052wk High0.51P/B46.62MFloat Cap3.85052wk Low--Dividend TTM10.50MShs Float26.620Historical High--Div YieldTTM7.52%Amplitude3.850Historical Low4.632Avg Price1Lot Size
BioAge Labs Stock Forum
Sign in to post a comment
$BioAge Labs (BIOA.US)$
Milestone Achievement: Alzheimer's Breakthrough Leqembi Reaches €200M Sales, Triggering Major Payout
Milestone Achievement: Alzheimer's Breakthrough Leqembi Reaches €200M Sales, Triggering Major Payout
1
The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
107
12
268
$BioAge Labs (BIOA.US)$ no volume
$BioAge Labs (BIOA.US)$ this one dead
$BioAge Labs (BIOA.US)$ Dead. No more hope
$BioAge Labs (BIOA.US)$
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
Tuesday, 28th January at 9:00 am
Advancement of next-generation APJ agonists with discontinuation of azelaprag
Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 2025
Expansion of discovery efforts based on insights from BioAge's platform, including a target identification collaboration with Novartis and a newly announced antibo...
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
Tuesday, 28th January at 9:00 am
Advancement of next-generation APJ agonists with discontinuation of azelaprag
Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 2025
Expansion of discovery efforts based on insights from BioAge's platform, including a target identification collaboration with Novartis and a newly announced antibo...
2
1
$BioAge Labs (BIOA.US)$ this stock is dead
$BioAge Labs (BIOA.US)$ No volume
$BioAge Labs (BIOA.US)$ institution is accumulating so just be patience
1
$BioAge Labs (BIOA.US)$ super slow and no volume
No comment yet
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!
Fortune Smiles 88 : what has to do with BIOA?